Federal contract award
15B41226P00000082
FY26 B1 CURASCRIPT MEDICATION - TYVASO FEB 26
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Justice |
| Office | FMC ROCHESTER |
| NAICS | 424210 — Drugs and Druggists' Sundries Merchant Wholesalers |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $21.7K |
| Current contract value | $21.7K |
| Potential contract value / ceiling | $21.7K |
| Start date | Feb 1, 2026 |
| Current end date | Feb 28, 2026 |
| Potential end date | Feb 28, 2026 |
| Latest award activity | May 6, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 6, 2026 | P00001 | $-1.4K | FY26 B1 CURASCRIPT MEDICATION - TYVASO FEB 26 THIS MODIFICATION REPRESENTS A DECREASE OF $1,394.80 |
| Feb 25, 2026 | 0 | $23.1K | FY26 B1 CURASCRIPT MEDICATION - TYVASO FEB 26 |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.